Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy-Reference-Cited by-同舟云学术

Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy

Published:2013-08 Issue:1-3 Volume:714 Page:472-477
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Cernecka Hana,Ochodnicka-Mackovicova Katarina,Kucerova Dana,Kmecova Jana,Nemcekova Viera,Doka Gabriel,Kyselovic Jan,Krenek Peter,Ochodnicky Peter,Klimas Jan

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Subchronic exposure to high-dose ACE-inhibitor moexipril induces catalase activity in rat liver;Adeghate;Mol. Cell. Biochem.,2005

2. Daunomycin: a cardiotoxic agent;Ainger;J. Natl. Med. Assoc.,1971

3. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat;Braissant;Endocrinology,1996

4. Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity;Boucek;Cardiovasc. Toxicol.,2003

5. Contractile failure in chronic doxorubicin-induced cardiomyopathy;Boucek;J. Mol. Cell Cardiol.,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up;Clinical Science;2022-01

2. Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2021-11-22

3. Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy;Russian Journal of Cardiology;2021-10-19

4. Diallyl sulfide protects against dilated cardiomyopathy via inhibition of oxidative stress and apoptosis in mice;Molecular Medicine Reports;2021-10-13

5. The tyrosine kinase inhibitor crizotinib influences blood glucose and mRNA expression of GLUT4 and PPARs in the heart of rats with experimental diabetes;Canadian Journal of Physiology and Pharmacology;2021-06